Effect of yoga on glycemic control and inflammation in type 2 diabetes mellitus: a prospective non-randomized comparative interventional study.
DOI:
https://doi.org/10.51168/pk2zcf82Keywords:
Yoga, Type 2 diabetes mellitus, Insulin resistance, HbA1c, hsCRP, IL-6, IL-1βAbstract
Background:
Type 2 diabetes mellitus (T2DM) is characterized by persistent metabolic disturbance, insulin resistance, and a low-grade inflammatory state. Yoga may complement standard treatment by combining physical activity, breathing practices, relaxation, and stress regulation.
Objectives:
To evaluate changes in glycemic indices, insulin resistance, and selected inflammatory markers during a structured 45-day yoga program in patients with T2DM receiving routine medication.
Methods:
This prospective, non-randomized comparative interventional study included 100 adults with established T2DM attending the General Medicine outpatient department. Fifty participants continued routine antidiabetic medication alone, while 50 received the same routine treatment together with a supervised 60-minute yoga session daily for 45 days. Venous blood was collected on days 0, 15, 30, and 45 for fasting blood sugar (FBS), HbA1c, insulin, HOMA-IR, high-sensitivity C-reactive protein (hsCRP), interleukin-1β (IL-1β), and interleukin-6 (IL-6).
Conclusion:
A 45-day supervised yoga program, when added to routine medication, was associated with better glycemic control, lower insulin resistance, and reduced inflammatory marker levels in patients with T2DM.
Recommendations:
Yoga can be considered as a supportive component of diabetes care for suitable patients. Longer studies with clearly defined allocation procedures and broader lifestyle assessment are warranted.
References
1. Raveendran AV, Deshpande A, Joshi SR. Therapeutic role of yoga in type 2 diabetes. Endocrinol Metab (Seoul). 2018;33:307-317. https://doi.org/10.3803/EnM.2018.33.3.307
2. Schwartz SS, Jellinger PS, Herman ME. Obviating much of the need for insulin therapy in type 2 diabetes mellitus: a reassessment of insulin therapy's safety profile. Postgrad Med. 2016;128:609-619. https://doi.org/10.1080/00325481.2016.1191955
3. Wannamethee SG, Lowe GDO, Rumley A, Cherry L, Whincup PH, Sattar N. Adipokines and risk of type 2 diabetes in older men. Diabetes Care. 2007;30:1200-1205. https://doi.org/10.2337/dc06-2416
4. Gabay C. Interleukin-6 and chronic inflammation. Arthritis Res Ther. 2006;8 Suppl 2:S3. https://doi.org/10.1186/ar1917
5. Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, Spinas GA, et al. Glucose-induced beta-cell production of IL-1β messenger ribonucleic acid expression in beta-cells of individuals with type 2 diabetes and regulation of IL-1β in human islets by glucose and autostimulation. J Clin Endocrinol Metab. 2008;93:4065-4074. https://doi.org/10.1210/jc.2008-0396
6. Neena S, Neeru G. Effect of yoga on glycemic profile in diabetics. Int J Med Sci Public Health. 2014;3:1135-1140. https://doi.org/10.5455/ijmsph.2014.020720141
7. Central Council for Research in Yoga & Naturopathy. Diabetes yoga protocol. Available from: http://ccryn.gov.in/sites/default/files/Diabetes.pdf
8. Kudigra S, Venkatram, Akanksha NS. Effect of yoga therapy on fasting blood sugar and to study the distribution of anthropometric measures in type 2 diabetes. Int J Complement Alt Med. 2018;11:44-47. https://doi.org/10.15406/ijcam.2018.11.00345
9. Singh S, Kyizom T, Singh KP, Tandon OP, Madhu SV. Influence of pranayamas and yoga-asanas on serum insulin, blood glucose and lipid profile in type 2 diabetes. Indian J Clin Biochem. 2008;23:365-368. https://doi.org/10.1007/s12291-008-0080-9
10. Kosuri M, Sridhar GR. Yoga practice in diabetes improves physical and psychological outcomes. Metab Syndr Relat Disord. 2009;7:515-517. https://doi.org/10.1089/met.2009.0011
11. Effoe VS, Correa A, Chen H, Lacy ME, Bertoni AG. High-sensitivity C-reactive protein is associated with incident type 2 diabetes among African Americans: the Jackson Heart Study. Diabetes Care. 2015;38:1694-1700. https://doi.org/10.2337/dc15-0221
12. Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, Spinas GA, et al. Glucose-induced beta-cell production of IL-1β contributes to glucotoxicity in human pancreatic islets. J Clin Invest. 2002;110:851-860. https://doi.org/10.1172/JCI200215318
13. Rajbhoj PH, Shete SU, Verma A, Bhogal RS. Effect of yoga module on pro-inflammatory and anti-inflammatory cytokines in industrial workers of Lonavla: a randomized controlled trial. J Clin Diagn Res. 2015;9:CC01-CC05. https://doi.org/10.7860/JCDR/2015/11426.5551
14. Shete SU, Verma A, Kulkarni DD, Bhogal RS. Effect of yoga training on inflammatory cytokines and C-reactive protein in employees of small-scale industries. J Educ Health Promot. 2017;6:76. https://doi.org/10.4103/jehp.jehp_65_17
15. Djalilova DM, Schulz PS, Berger AM, Case AJ, Kupzyk KA, Ross AC. Impact of yoga on inflammatory biomarkers: a systematic review. Biol Res Nurs. 2019;21:198-209. https://doi.org/10.1177/1099800418820162
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Dr. Viswa Kalyan Kolli, Dr. Sai Praneeth Nalla, Dr. Jhansi Rani Nannapaneni

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.














